Vaccines, antibodies, and pharmaceutical proteins

Plant Biotechnology and Agriculture

Volumn , Issue , 2012, Pages 465-479

  Gleba, Yuri Y ^a   Giritch, Anatoli ^a  

^a Nomad Bioscience GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883977872     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381466-1.00029-8     Document Type: Chapter

References (109)

1. Alvarez M.L., Topal E., Martin F., Cardineau G.A. Higher accumulation of F1-V fusion recombinant protein in plants after induction of protein body formation. Plant Molecular Biology 2010, 72:75-89.
2. Arlen P.A., Falconer R., Cherukumilli S., Cole A., Cole A.M., Oishi K.K., et al. Field production and functional evaluation of chloroplast-derived interferon-alpha2b. Plant Biotechnology Journal 2007, 5:511-525.
3. Arlen P.A., Singleton M., Adamovicz J.J., Ding Y., Davoodi-Semiromi A., Daniell H. Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. Infection Control and Hospital Epidemiology 2008, 76:3640-3650.
4. Bakker H., Bardor M., MolthoffJ.W., Gomord V., Elbers I., Stevens L.H., et al. Galactose-extended glycans of antibodies produced by transgenic plants. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:2899-2904.
5. Bendandi M., Marillonnet S., Kandzia R., Thieme F., Nickstadt A., Herz S., et al. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma. Annals of Oncology 2010, 21(12):2420-2427.
6. Bock R. Plastid biotechnology: prospects for herbicide and insect resistance, metabolic engineering and molecular farming. Current Opinion in Biotechnology 2007, 18:100-106.
7. Boothe J., Nykiforuk C., Shen Y., Zaplachinski S., Szarka S., Kuhlman P., et al. Seed-based expression systems for plant molecular farming. Plant Biotechnology Journal 2010, 8:588-606.
8. Canizares M.C., LomonossoffG.P., Nicholson L. Development of cowpea mosaic virus-based vectors for the production of vaccines in plants. Expert Review of Vaccines 2005, 4:687-697.
9. Canizares M.C., Nicholson L., LomonossoffG.P. Use of viral vectors for vaccine production in plants. Immunology and Cell Biology 2005, 83:263-270.
10. Cao Y., Zhang Q., Wang C., Zhu Y., Bai G. Preparation of novel immunomagnetic cellulose microspheres via cellulose binding domain-protein A linkage and its use for the isolation of interferon alpha-2b. Journal of Chromatography A 2007, 1149:228-235.
11. Castilho A., Strasser R., Stadlmann J., Grass J., Jez J., Gattinger P., et al. In planta protein sialylation through overexpression of the respective mammalian pathway. Journal of Biological Chemistry 2010, 285:15923-15930.
12. Chebolu S., Daniell H. Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis. Plant Biotechnology Journal 2007, 5:230-239.
13. Conley A.J., Joensuu J.J., Jevnikar A.M., Menassa R., Brandle J.E. Optimization of elastin-like polypeptide fusions for expression and purification of recombinant proteins in plants. Biotechnology and Bioengineering 2009, 103:562-573.
14. Conley A.J., Joensuu J.J., Menassa R., Brandle J.E. Induction of protein body formation in plant leaves by elastin-like polypeptide fusions. BMC Biology 2009, 7:48.
15. Conrad U., Plagmann I., Malchow S., Sack M., Floss D.M., Kruglov A.A., et al. ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock. Plant Biotechnology Journal 2011, 9(1):22-31.
16. Cox K.M., Sterling J.D., Regan J.T., Gasdaska J.R., Frantz K.K., Peele C.G., et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nature Biotechnology 2006, 24:1591-1597.
17. Daniell H., Ruiz G., Denes B., Sandberg L., Langridge W. Optimization of codon composition and regulatory elements for expression of human insulin like growth factor-1 in transgenic chloroplasts and evaluation of structural identity and function. BMC Biotechnology 2009, 9:33.
18. Daniell H., Singh N.D., Mason H., Streatfield S.J. Plant-made vaccine antigens and biopharmaceuticals. Trends in Plant Science 2009, 14:669-679.
19. Davoodi-Semiromi A., Samson N., Daniell H. The green vaccine: A global strategy to combat infectious and autoimmune diseases. Human Vaccines 2009, 5:488-493.
20. Davoodi-Semiromi A., Schreiber M., Nalapalli S., Verma D., Singh N.D., Banks R.K., et al. Chloroplast-derived vaccine antigens confer dual immunity against cholera and malaria by oral or injectable delivery. Plant Biotechnology Journal 2010, 8:223-242.
21. De Jaeger G., Scheffer S., Jacobs A., Zambre M., Zobell O., Goossens A., et al. Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences. Nature Biotechnology 2002, 20:1265-1268.
22. De Muynck B., Navarre C., Boutry M. Production of antibodies in plants: Status after twenty years. Plant Biotechnology Journal 2010, 8:529-563.
23. Decker E.L., Reski R. Current achievements in the production of complex biopharmaceuticals with moss bioreactors. Bioprocess and Biosystems Engineering 2008, 31:3-9.
24. Donson J., Kearney C.M., Hilf M.E., Dawson W.O. Systemic expression of a bacterial gene by a tobacco mosaic virus-based vector. Proceedings of the National Academy of Sciences of the United States of America 1991, 88:7204-7208.
25. Dorokhov Y.L., Sheveleva A.A., Frolova O.Y., Komarova T.V., Zvereva A.S., Ivanov P.A., et al. Superexpression of tuberculosis antigens in plant leaves. Tuberculosis (Edinb) 2007, 87:218-224.
26. Fernandez-San Millan A., Ortigosa S.M., Hervas-Stubbs S., Corral-Martinez P., Segui-Simarro J.M., Gaetan J., et al. Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnology Journal 2008, 6:427-441.
27. Fischer R., Stoger E., Schillberg S., Christou P., Twyman R.M. Plant-based production of biopharmaceuticals. Current Opinion in Plant Biology 2004, 7:152-158.
28. Floss D.M., Sack M., Arcalis E., Stadlmann J., Quendler H., Rademacher T., et al. Influence of elastin-like peptide fusions on the quantity and quality of a tobacco-derived human immunodeficiency virus-neutralizing antibody. Plant Biotechnology Journal 2009, 7:899-913.
29. Floss D.M., Sack M., Stadlmann J., Rademacher T., Scheller J., Stoger E., et al. Biochemical and functional characterization of anti-HIV antibody-ELP fusion proteins from transgenic plants. Plant Biotechnology Journal 2008, 6:379-391.
30. Floss D.M., Schallau K., Rose-John S., Conrad U., Scheller J. Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application. Trends in Biotechnology 2010, 28:37-45.
31. Fujiki M., Kaczmarczyk J.F., Yusibov V., Rabindran S. Development of a new cucumber mosaic virus-based plant expression vector with truncated 3a movement protein. Virology 2008, 381:136-142.
32. Gils M., Kandzia R., Marillonnet S., Klimyuk V., Gleba Y. High-yield production of authentic human growth hormone using a plant virus-based expression system. Plant Biotechnology Journal 2005, 3:613-620.
33. Giritch A., Marillonnet S., Engler C., van Eldik G., Botterman J., Klimyuk V., et al. Rapid high-yield expression of full-size IgG antibodies in plants coinfected with noncompeting viral vectors. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:14701-14707.
34. Gleba Y., Klimyuk V., Marillonnet S. Magnifection - a new platform for expressing recombinant vaccines in plants. Vaccine 2005, 23:2042-2048.
35. Gleba Y., Klimyuk V., Marillonnet S. Viral vectors for the expression of proteins in plants. Current Opinion in Biotechnology 2007, 18:134-141.
36. Gleba Y., Marillonnet S., Klimyuk V. Engineering viral expression vectors for plants: The "full virus" and the "deconstructed virus" strategies. Current Opinion in Plant Biology 2004, 7:182-188.
37. Gleba Y., Marillonnet S., Klimyuk V. Plant virus vectors (gene expression systems). Encyclopedia of virology 2007, Vol. 4:229-237. Academic Press, San Diego. 3 rd ed.
38. Glenz K., Bouchon B., Stehle T., Wallich R., Simon M.M., Warzecha H. Production of a recombinant bacterial lipoprotein in higher plant chloroplasts. Nature Biotechnology 2006, 24:76-77.
39. Gorr G., Altmann F. Glycosylation of recombinant proteins in plants. Medicinal Plant Biotechnology 2006, Vol. 2:345-374. Wiley-VCH.
40. Green B.J., Fujiki M., Mett V., Kaczmarczyk J., Shamloul M., Musiychuk K., et al. Transient protein expression in three Pisum sativum (green pea) varieties. Biotechnology Journal 2009, 4:230-237.
41. Hellwig S., Drossard J., Twyman R.M., Fischer R. Plant cell cultures for the production of recombinant proteins. Nature Biotechnology 2004, 22:1415-1422.
42. Hennegan K., Yang D., Nguyen D., Wu L., Goding J., Huang J., et al. Improvement of human lysozyme expression in transgenic rice grain by combining wheat (Triticum aestivum) puroindoline b and rice (Oryza sativa) Gt1 promoters and signal peptides. Transgenic Research 2005, 14:583-592.
43. Hood E.E., Love R., Lane J., Bray J., Clough R., Pappu K., et al. Subcellular targeting is a key condition for high-level accumulation of cellulase protein in transgenic maize seed. Plant Biotechnology Journal 2007, 5:709-719.
44. Huang J., Nandi S., Wu L., Yalda D., Bartley G., Rodriguez R., et al. Expression of natural antimicrobial human lysozyme in rice grains. Molecular Breeding 2002, 10:83-94.
45. Huang Z., Chen Q., Hjelm B., Arntzen C., Mason H. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnology and Bioengineering 2009, 103:706-714.
46. Huang Z., Phoolcharoen W., Lai H., Piensook K., Cardineau G., Zeitlin L., et al. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnology and Bioengineering 2009, 106(1):9-17.
47. Huang Z., Santi L., LePore K., Kilbourne J., Arntzen C.J., Mason H.S. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine 2006, 24:2506-2513.
48. Huhns M., Neumann K., Hausmann T., Klemke F., Lockau W., Kahmann U., et al. Tuber-specific cphA expression to enhance cyanophycin production in potatoes. Plant Biotechnology Journal 2009, 7:883-898.
49. Huhns M., Neumann K., Hausmann T., Ziegler K., Klemke F., Kahmann U., et al. Plastid targeting strategies for cyanophycin synthetase to achieve high-level polymer accumulation in Nicotiana tabacum. Plant Biotechnology Journal 2008, 6:321-336.
50. Hussack G., Grohs B.M., Almquist K.C., McLean M.D., Ghosh R., Hall J.C. Purification of plant-derived antibodies through direct immobilization of affinity ligands on cellulose. Journal of Agricultural and Food Chemistry 2010, 58:3451-3459.
51. Kalantidis K., Tsagris M., Tabler M. Spontaneous short-range silencing of a GFP transgene in Nicotiana benthamiana is possibly mediated by small quantities of siRNA that do not trigger systemic silencing. Plant Journal 2006, 45:1006-1016.
52. Karg S.R., Kallio P.T. The production of biopharmaceuticals in plant systems. Biotechnology Advances 2009, 27:879-884.
53. Ko K., Brodzik R., Steplewski Z. Production of antibodies in plants: Approaches and perspectives. Current Topics in Microbiology and Immunology 2009, 332:55-78.
54. Kogan M.J., Dalcol I., Gorostiza P., Lopez-Iglesias C., Pons M., Sanz F., et al. Self-assembly of the amphipathic helix (VHLPPP)8. A mechanism for zein protein body formation. Journal of Molecular Biology 2001, 312:907-913.
55. Koya V., Moayeri M., Leppla S.H., Daniell H. Plant-based vaccine: Mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infection Control and Hospital Epidemiology 2005, 73:8266-8274.
56. Kumagai M.H., Donson J., della-Cioppa G., Grill L.K. Rapid, high-level expression of glycosylated rice alpha-amylase in transfected plants by an RNA viral vector. Gene 2000, 245:169-174.
57. Kumagai M.H., Donson J., della-Cioppa G., Harvey D., Hanley K., Grill L.K. Cytoplasmic inhibition of carotenoid biosynthesis with virus-derived RNA. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:1679-1683.
58. Kumagai M.H., Turpen T.H., Weinzettl N., della-Cioppa G., Turpen A.M., Donson J., et al. Rapid, high-level expression of biologically active alpha-trichosanthin in transfected plants by an RNA viral vector. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:427-430.
59. Kushwaha A., Chowdhury P.S., Arora K., Abrol S., Chaudhary V.K. Construction and characterization of M13 bacteriophages displaying functional IgG-binding domains of staphylococcal protein A. Gene 1994, 151:45-51.
60. Lico C., Chen Q., Santi L. Viral vectors for production of recombinant proteins in plants. Journal of Cellular Physiology 2008, 216:366-377.
61. Lindbo J.A. High-efficiency protein expression in plants from agroinfection-compatible Tobacco mosaic virus expression vectors. BMC Biotechnology 2007, 7:52.
62. Lindbo J.A. TRBO: A high-efficiency tobacco mosaic virus RNA-based overexpression vector. Plant Physiology 2007, 145:1232-1240.
63. Maclean J., Koekemoer M., Olivier A.J., Stewart D., Hitzeroth II, Rademacher T., et al. Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: Comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localization. Journal of General Virology 2007, 88:1460-1469.
64. Marillonnet S., Giritch A., Gils M., Kandzia R., Klimyuk V., Gleba Y. In planta engineering of viral RNA replicons: Efficient assembly by recombination of DNA modules delivered by Agrobacterium. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:6852-6857.
65. Marillonnet S., Thoeringer C., Kandzia R., Klimyuk V., Gleba Y. Systemic Agrobacterium tumefaciens-mediated transfection of viral replicons for efficient transient expression in plants. Nature Biotechnology 2005, 23:718-723.
66. McCabe M.S., Klaas M., Gonzalez-Rabade N., Poage M., Badillo-Corona J.A., Zhou F., et al. Plastid transformation of high-biomass tobacco variety Maryland Mammoth for production of human immunodeficiency virus type 1 (HIV-1) p24 antigen. Plant Biotechnology Journal 2008, 6:914-929.
67. McCormick A.A., Palmer K.E. Genetically engineered Tobacco mosaic virus as nanoparticle vaccines. Expert Review of Vaccines 2008, 7:33-41.
68. McCormick A.A., Kumagai M.H., Hanley K., Turpen T.H., Hakim I., Grill L.K., et al. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:703-708.
69. McCormick A.A., Reddy S., Reinl S.J., Cameron T.I., Czerwinkski D.K., Vojdani F., et al. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: Safety and immunogenicity in a phase I clinical study. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:10131-10136.
70. McCormick A.A., Reinl S.J., Cameron T.I., Vojdani F., Fronefield M., Levy R., et al. Individualized human scFv vaccines produced in plants: Humoral anti-idiotype responses in vaccinated mice confirm relevance to the tumor Ig. Journal of Immunological Methods 2003, 278:95-104.
71. Mett V., Farrance C.E., Green B.J., Yusibov V. Plants as biofactories. Biologicals 2008, 36:354-358.
72. Molina A., Veramendi J., Hervas-Stubbs S. Induction of neutralizing antibodies by a tobacco chloroplast-derived vaccine based on a B cell epitope from canine parvovirus. Virology 2005, 342:266-275.
73. Nandi S., Yalda D., Lu S., Nikolov Z., Misaki R., Fujiyama K., et al. Process development and economic evaluation of recombinant human lactoferrin expressed in rice grain. Transgenic Research 2005, 14:237-249.
74. Nechansky A., Schuster M., Jost W., Siegl P., Wiederkum S., Gorr G., et al. Compensation of endogenous IgG mediated inhibition of antibody-dependent cellular cytotoxicity by glyco-engineering of therapeutic antibodies. Molecular Immunology 2007, 44:1815-1817.
75. Nomellini J.F., Duncan G., Dorocicz I.R., Smit J. S-layer-mediated display of the immunoglobulin G-binding domain of streptococcal protein G on the surface of Caulobacter crescentus: Development of an immunoactive reagent. Applied and Environmental Microbiology 2007, 73:3245-3253.
76. Oey M., Lohse M., Kreikemeyer B., Bock R. Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant Journal 2009, 57:436-445.
77. Oey M., Lohse M., ScharffL.B., Kreikemeyer B., Bock R. Plastid production of protein antibiotics against pneumonia via a new strategy for high-level expression of antimicrobial proteins. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:6579-6584.
78. O'Keefe B.R., Vojdani F., Buffa V., Shattock R.J., Montefiori D.C., Bakke J., et al. Scaleable manufacture of HIV-1 entry inhibitor griffithsin and validation of its safety and efficacy as a topical microbicide component. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:6099-6104.
79. Outchkourov N.S., Peters J., de Jong J., Rademakers W., Jongsma M.A. The promoter-terminator of chrysanthemum rbcS1 directs very high expression levels in plants. Planta 2003, 216:1003-1012.
80. Palacpac N.Q., Yoshida S., Sakai H., Kimura Y., Fujiyama K., Yoshida T., et al. Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:4692-4697.
81. Plasson C., Michel R., Lienard D., Saint-Jore-Dupas C., Sourrouille C., de March G.G., et al. Production of recombinant proteins in suspension-cultured plant cells. Methods in Molecular Biology 2009, 483:145-161.
82. Rabindran S., Dawson W.O. Assessment of recombinants that arise from the use of a TMV-based transient expression vector. Virology 2001, 284:182-189.
83. Roque A.C., Lowe C.R., Taipa M.A. Antibodies and genetically engineered related molecules: Production and purification. Biotechnology Progress 2004, 20:639-654.
84. Rybicki E.P. Plant-produced vaccines: Promise and reality. Drug Discovery Today 2009, 14:16-24.
85. Sainsbury F., LomonossoffG.P. Extremely high-level and rapid transient protein production in plants without the use of viral replication. Plant Physiology 2008, 148:1212-1218.
86. Sainsbury F., Liu L., LomonossoffG.P. Cowpea mosaic virus-based systems for the expression of antigens and antibodies in plants. Methods in Molecular Biology 2009, 483:25-39.
87. Santi L., Batchelor L., Huang Z., Hjelm B., Kilbourne J., Arntzen C.J., et al. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine 2008, 26:1846-1854.
88. Santi L., Giritch A., Roy C.J., Marillonnet S., Klimyuk V., Gleba Y., et al. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:861-866.
89. Santi L., Huang Z., Mason H. Virus-like particles production in green plants. Methods 2006, 40:66-76.
90. Schahs M., Strasser R., Stadlmann J., Kunert R., Rademacher T., Steinkellner H. Production of a monoclonal antibody in plants with a humanized N-glycosylation pattern. Plant Biotechnology Journal 2007, 5:657-663.
91. Schuster M., Jost W., Mudde G.C., Wiederkum S., Schwager C., Janzek E., et al. In vivo glyco-engineered antibody with improved lytic potential produced by an innovative non-mammalian expression system. Biotechnology Journal 2007, 2:700-708.
92. Shivprasad S., Pogue G.P., Lewandowski D.J., Hidalgo J., Donson J., Grill L.K., et al. Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors. Virology 1999, 255:312-323.
93. Smith M.L., Fitzmaurice W.P., Turpen T.H., Palmer K.E. Display of peptides on the surface of tobacco mosaic virus particles. Current Topics in Microbiology and Immunology 2009, 332:13-31.
94. Strasser R., Stadlmann J., Schahs M., Stiegler G., Quendler H., Mach L., et al. Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. Plant Biotechnology Journal 2008, 6:392-402.
95. Torrent M., Llompart B., Lasserre-Ramassamy S., Llop-Tous I., Bastida M., Marzabal P., et al. Eukaryotic protein production in designed storage organelles. BMC Biology 2009, 7:5.
96. Torrent M., Llop-Tous I., Ludevid M.D. Protein body induction: A new tool to produce and recover recombinant proteins in plants. Methods in Molecular Biology 2009, 483:193-208.
97. Tregoning J.S., Nixon P., Kuroda H., Svab Z., Clare S., Bowe F., et al. Expression of tetanus toxin Fragment C in tobacco chloroplasts. Nucleic Acids Research 2003, 31:1174-1179.
98. Turpen T.H. Tobacco mosaic virus and the virescence of biotechnology. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences 1999, 354:665-673.
99. Turpen T.H., Reinl S.J., Charoenvit Y., Hoffman S.L., Fallarme V., Grill L.K. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus. Biotechnology (NY) 1995, 13:53-57.
100. Vancanneyt G., Dubald M., Schroder W., Peters J., Botterman J. A case study for plant-made pharmaceuticals comparing different plant expression and production systems. Methods in Molecular Biology 2009, 483:209-221.
101. Verwoerd T.C., van Paridon P.A., van Ooyen A.J., van Lent J.W., Hoekema A., Pen J. Stable accumulation of Aspergillus niger phytase in transgenic tobacco leaves. Plant Physiology 1995, 109:1199-1205.
102. Vezina L.P., Faye L., Lerouge P., D'Aoust M.A., Marquet-Blouin E., Burel C., et al. Transient co-expression for fast and high-yield production of antibodies with human-like N-glycans in plants. Plant Biotechnology Journal 2009, 7:442-455.
103. Vollenkle C., Weigert S., Ilk N., Egelseer E., Weber V., Loth F., et al. Construction of a functional S-layer fusion protein comprising an immunoglobulin G-binding domain for development of specific adsorbents for extracorporeal blood purification. Applied and Environmental Microbiology 2004, 70:1514-1521.
104. Watson J., Koya V., Leppla S.H., Daniell H. Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop. Vaccine 2004, 22:4374-4384.
105. Webster D.E., Wang L., Mulcair M., Ma C., Santi L., Mason H.S., et al. Production and characterization of an orally immunogenic Plasmodium antigen in plants using a virus-based expression system. Plant Biotechnology Journal 2009, 7:846-855.
106. Weise A., Altmann F., Rodriguez-Franco M., Sjoberg E.R., Baumer W., Launhardt H., et al. High-level expression of secreted complex glycosylated recombinant human erythropoietin in the Physcomitrella Delta-fuc-t Delta-xyl-t mutant. Plant Biotechnology Journal 2007, 5:389-401.
107. Werner S., Marillonnet S., Hause G., Klimyuk V., Gleba Y. Immunoabsorbent nanoparticles based on a tobamovirus displaying protein A. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:17678-17683.
108. Yusibov V., Rabindran S. Recent progress in the development of plant derived vaccines. Expert Review of Vaccines 2008, 7:1173-1183.
109. Zvereva A.S., Petrovskaya L.E., Rodina A.V., Frolova O.Y., Ivanov P.A., Shingarova L.N., et al. Production of biologically active human myelocytokines in plants. Biochemistry (Mosc) 2009, 74:1187-1194.